We provide you with 20 years of free, institutional-grade data for EDSA stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of EDSA. Explore the full financial landscape of EDSA stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|
The information provided in this report about EDSA stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Edesa Biotech, Inc(NASDAQ:EDSA) 
Edesa Biotech, Inc., a clinical-stage biopharmaceutical company, engages in the research and development, manufacture, and commercialization of pharmaceutical products for inflammatory and immune-related diseases. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 2/Phase...
Website: http://www.edesabiotech.com
Founded: 2007
Full Time Employees: 12
CEO: Pardeep Nijhawan
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends